Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Validity of sentinel node biopsy in early oral and oropharyngeal carcinoma.

Riese CGU, Karstadt JA, Schramm A, Güleryüz S, Dressel G, Lorenz KJ, Klemenz B, Sailer A, Seitz S, Wilde F.

J Craniomaxillofac Surg. 2018 Oct;46(10):1748-1752. doi: 10.1016/j.jcms.2018.07.021. Epub 2018 Aug 3.

PMID:
30145047
2.

18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer.

McKinley ET, Bugaj JE, Zhao P, Guleryuz S, Mantis C, Gokhale PC, Wild R, Manning HC.

Clin Cancer Res. 2011 May 15;17(10):3332-40. doi: 10.1158/1078-0432.CCR-10-2274. Epub 2011 Jan 21.

3.

Molecular imaging metrics to evaluate response to preclinical therapeutic regimens.

Smith RA, Guleryuz S, Manning HC.

Front Biosci (Landmark Ed). 2011 Jan 1;16:393-410. Review.

4.

Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline.

Buck JR, McKinley ET, Hight MR, Fu A, Tang D, Smith RA, Tantawy MN, Peterson TE, Colvin D, Ansari MS, Baldwin RM, Zhao P, Guleryuz S, Manning HC.

J Nucl Med. 2011 Jan;52(1):107-14. doi: 10.2967/jnumed.110.081703. Epub 2010 Dec 13.

5.

Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.

Yildiz A, Guleryuz S, Ankerst DP, Ongür D, Renshaw PF.

Arch Gen Psychiatry. 2008 Mar;65(3):255-63. doi: 10.1001/archgenpsychiatry.2007.43.

PMID:
18316672

Supplemental Content

Loading ...
Support Center